{"nct_id":"NCT05506969","title":"Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2022-08-09","start_date_type":"ACTUAL","primary_completion_date":"2023-10-03","primary_completion_date_type":"ACTUAL","completion_date":"2024-04-26","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["DVAX"]}